Turn to the nation's most objective and informative daily environmental news resource to learn how the United States and key players around the world are responding to the environmental...
Formaldehyde has been identified as a known human carcinogen in a report released by the Department of Health and Human Services June 10.
The report also lists styrene as a reasonably anticipated human carcinogen.
The two commonly used industrial chemicals are among eight substances added to the 12th Report on Carcinogens, a congressionally mandated report prepared for HHS by the National Toxicology Program.
Worker studies have shown that formaldehyde, which is widely used in production of building materials such as pressed wood, can cause myeloid leukemia along with cancers in the sinuses and upper throat, the report said.
In addition, aristolochic acids, a family of naturally occurring chemicals in plants grown in the United States and other countries, were classified as known human carcinogens.
The Food and Drug Administration issued a warning in 2001 advising against the consumption of herbal products with aristolochic acids due to concerns including the risk of cancer, but they remain on the market, NTP said in a fact sheet about the botanicals.
Human studies have provided “limited evidence” that styrene caused blood cancers such as leukemia, the report said. That evidence was supported by genetic damage found in exposed workers that could lead to cancer, it said.
Additional evidence came from laboratory studies in several strains of mice, the 12th report said.
Five other substances were classified as reasonably anticipated human carcinogens:
Not all glass wool or man-made fibers were found to be carcinogenic, NTP said in announcing the report's release.
“The specific glass wool fibers referred to in this report … include only those fibers that can enter the respiratory tract, are highly durable, and are biopersistent, meaning they remain in the lungs for long periods of time,” NTP said.
Riddelliine, a chemical found in some plants in the western United States, also was classified as a reasonably anticipated human carcinogen. The chemical has no known commercial uses in the United States, the 12th report said.
“However, the riddelliine-containing plant Senecio longilobus has been used in medicinal herb preparations in the United States, and S. jacobaea and S. vulgaris, both of which have been shown to contain riddelliine, are used in medicinal preparations in other parts of the world,” the report said.
The Report on Carcinogens is developed through a multi-step process with multiple opportunities for peer review and public comment. HHS makes the final decisions on classifications.
The 12th report includes 240 listings, some of which are classes of related chemicals or substances; 54 substances are listed as known human carcinogens, and 186 are reasonably anticipated to be human carcinogens.
By Pat Rizzuto
12th Report on Carcinogens and related documents are available at http://ntp.niehs.nih.gov/?objectid=72016262-BDB7-CEBA-FA60E922B18C2540.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)